New Findings
Latest Conference Posters & Presentations
Browse the latest conference posters and presentations below. Click the arrow next to each conference name to view more details.
Following the conclusion of the 2026 European Stroke Organisation Conference, we are pleased to share a summary of Bayer’s scientific contributions. Posters and presentations from the meeting are included below.
LATE-BREAKER SESSIONS
Incident ischaemic stroke in the randomised, placebo-controlled, event-driven oceanic-stroke trial of asundexian for secondary stroke prevention
Presenting Author: Mukul Sharma
Date/Time: Wednesday, May 6 | 11:51 AM – 12:01 PM, CEST
Session: Official Welcome & Large Clinical Trials (LB157)
Location: Peking
Net benefit and time course of benefit of asundexian for secondary stroke prevention in the oceanic-stroke randomised, placebo-controlled clinical trial
Presenting Author: Mukul Sharma
Date/Time: Friday, May 8 | 9:15 AM – 9:24 AM, CEST
Session: Late Breaking Trials Across the Stroke Care Continuum (LB158)
Location: Peking
Predictors of recurrent ischaemic stroke in patients with non-cardioembolic ischaemic stroke
Presenting Author: Ashkan Shoamanesh
Date/Time: Wednesday, May 6 | 1:00 PM, CEST
Session: Paper Poster Presentation Session (LB159)
Location: Poster Area
Intracranial haemorrhage in patients with non-cardioembolic ischaemic stroke or high-risk TIA
Presenting Author: Ashkan Shoamanesh
Date/Time: Wednesday, May 6 | 1:00 PM, CEST
Session: Paper Poster Presentation Session (LB160)
Location: Poster Area
POSTER PRESENTATIONS
Evaluating real-world outcomes of single versus dual antiplatelet therapy after an ischaemic stroke: mortality and major adverse cardiovascular events
Presenting Author: Steven Caproni
Date/Time: Wednesday, May 6 | 1:00 PM, CEST
Session: Paper Poster Presentation Session (A411)
Location: Poster Area
The impact of recurrent ischaemic stroke on length of stay and all-cause costs in patients with non-cardioembolic ischaemic stroke in Japan: observations from ARISE
Presenting Author: Ryu Matsuo
Date/Time: Wednesday, May 6 | 1:00 PM, CEST
Session: Paper Poster Presentation Session (A403)
Location: Poster Area
Characteristics and clinical outcomes in patients with TIA by ABCD2 score: a retrospective observational study of a representative US EHR database
Presenting Author: Thanh N. Nguyen
Date/Time: Thursday, May 7 | 1:00 PM, CEST
Session: Paper Poster Presentation Session (A525)
Location: Poster Area
Medication patterns by stroke severity in non-cardioembolic ischaemic stroke: findings from a large, nationally representative US-based retrospective observational database
Presenting Author: Sean Savitz
Date/Time: Thursday, May 7 | 1:00 PM, CEST
Session: Paper Poster Presentation Session (A1430)
Location: Poster Area
E-POSTERS
Analysis of characteristics and clinical outcomes after ischaemic stroke by NIHSS in a nationally representative US electronic health records database
Authors: Mathew Reeves, et al.
Session: ePoster
Functional impairment patterns following recurrent ischaemic stroke in patients with a history of non-cardioembolic stroke: an observational study
Authors: Stine Munk Hald, et al.
Session: ePoster
Real-world patient characteristics and clinical outcomes across stroke TOAST subtypes: analysis of a large representative US electronic health record database
Authors: Ashkan Shoamanesh, et al.
Session: ePoster
The compendium provided by Bayer is a compilation of Bayer-sponsored presentations. Copies of presentations obtained from this compendium are for personal use only and may not be reproduced or distributed without permission from ESOC and from the authors. The compounds presented may be investigational or are being investigated for uses that have not been approved by Health Canada, the US Food and Drug Administration (FDA), European Medicines Agency (EMA), or other health authorities, and the data referenced here may be considered investigational. This information is presented only for the purposes of providing a general overview of clinical trials and should not be construed as a recommendation for use of any product for unapproved uses. Data presented at conferences (abstracts, oral presentations, posters) may differ from final publication in peer-reviewed journals.
MA-M_ASUN-CA-0025-1